Search

Smith & Nephew PLC

Fechado

1,263 -1.41

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1258.5

Máximo

1280.5

Indicadores-chave

By Trading Economics

Rendimento

296M

Vendas

3B

P/E

Médio do Setor

30.104

22.135

EPS

0.429

Rendimento de Dividendos

3

Margem de lucro

9.895

Funcionários

17,000

EBITDA

723M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+18.25% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.00%

4.29%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2.9B

12B

Abertura anterior

1264.41

Fecho anterior

1263

Smith & Nephew PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de nov. de 2025, 21:34 UTC

Ganhos

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 de nov. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 de nov. de 2025, 23:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 de nov. de 2025, 23:41 UTC

Conversa de Mercado

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 de nov. de 2025, 23:24 UTC

Ganhos

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 de nov. de 2025, 23:24 UTC

Ganhos

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 de nov. de 2025, 23:23 UTC

Ganhos

JBS NV 3Q EPS 52c >JBS

13 de nov. de 2025, 23:23 UTC

Ganhos

JBS NV 3Q Sales $22.6B >JBS

13 de nov. de 2025, 23:04 UTC

Conversa de Mercado

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 de nov. de 2025, 22:02 UTC

Ganhos

Nu Holdings 3Q Net $783M >NU

13 de nov. de 2025, 22:01 UTC

Ganhos

Nu Holdings 3Q Rev $4.2B >NU

13 de nov. de 2025, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 de nov. de 2025, 21:50 UTC

Ganhos

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 de nov. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 de nov. de 2025, 21:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 de nov. de 2025, 21:33 UTC

Conversa de Mercado

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 de nov. de 2025, 21:33 UTC

Ganhos

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 de nov. de 2025, 21:31 UTC

Ganhos

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 de nov. de 2025, 21:25 UTC

Ganhos

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 de nov. de 2025, 21:25 UTC

Ganhos

Figure Tech Solutions 3Q EPS 34c >FIGR

13 de nov. de 2025, 21:23 UTC

Ganhos

Intchains Group 3Q Rev $1.3M >ICG

13 de nov. de 2025, 21:03 UTC

Ganhos

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 de nov. de 2025, 21:02 UTC

Ganhos

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 de nov. de 2025, 21:01 UTC

Ganhos

Applied Materials 4Q Rev $6.8B >AMAT

13 de nov. de 2025, 21:01 UTC

Ganhos

Applied Materials 4Q Gross Margin 48.0% >AMAT

Smith & Nephew PLC Previsão

Preço-alvo

By TipRanks

18.25% parte superior

Previsão para 12 meses

Média 1,516 GBX  18.25%

Máximo 1,700 GBX

Mínimo 1,300 GBX

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Smith & Nephew PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

8 ratings

5

Comprar

3

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat